SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ciba India Ltd (CIBASPEC) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 532184 NSE: CIBASPEC | Chemicals | Small Cap

BSE Share Price
Not Listed

Ciba India Ltd (CIBASPEC)

BSE: 532184 NSE: CIBASPEC
Key Metrics
Market Cap
₹438 Cr.
P/E Ratio
0.00
Price to Book (P/B)
1.50
Price to Sales (P/S)
0.99
EV/EBITDA
52.25
Return on Capital Employed (ROCE)
11.16%
Current Price
₹0
Return on Equity (ROE)
7.36%
Return on Assets (ROA)
5.37%
Operating Profit Margin
7.4%
Net Profit Margin
4.42%
Gross Profit Margin
7.8%
Book Value per Share
₹220.2
Sales Growth (YoY)
8.13%
Sales Growth (3 Years)
-6.73%
Operating Profit Growth (1 Year)
0.07%
Operating Profit Growth (3 Years)
-15.74%
Net Profit Growth (1 Year)
15.62%
52-Week Low / High
₹321 / 333
Net Profit Growth (3 Years)
-12.49%
Dividend Yield
1.64%
Promoter Holding
71.40%
Pledged shares (%)
of Promoter's holding (%)
0.00%

DeciZen - make an informed investing decision on Ciba India

Based on:

M-Cap below 100cr DeciZen not available

Ciba India stock performance

Key Ratios
mw4me loader

Is an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09TTM
ROCE % 25.8%28.5%26.3%15.1%11%19%25%37.9%10.9%11.2%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 440480478488454561624511468506445
Sales YoY Gr.-9.2%-0.6%2.2%-6.9%23.4%11.3%-18.1%-8.4%8.1%-
Adj EPS 13.810.117.514.110.220.22529.315.418.8-22
YoY Gr.--26.7%72.5%-19.5%-27.8%99.1%23.5%17.3%-47.5%21.9%-
BVPS (₹) 75.990.4109.8119.1125.7139.9157211.8222.3235220.2
Adj Net
Profit
18.413.523.218.713.526.933.238.920.424.9-29
Cash Flow from Ops. 24.15.223.4-2.948.739.135.6-8.923.67.6-
Debt/CF from Ops. 111.72.4-27.91.70.60.1-0.910.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 1.6%2.2%-6.7%8.1%
Adj EPS 3.5%13.1%-9.1%21.9%
BVPS13.4%13.3%14.4%5.7%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09TTM
Return on
Equity %
19.312.217.512.38.315.216.815.97.18.2-9.7
Op. Profit
Mgn %
7.65.66.76.85.488.26.46.97.4-1.3
Net Profit
Mgn %
4.22.84.93.834.85.37.64.44.9-6.6
Debt to
Equity
0.20.50.40.50.50.1000.10-
Working Cap
Days
1011131291441621281331551601630
Cash Conv.
Cycle
426074879772626559560

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials

Standalone Consolidated
TTM EPS (₹) -22 24.7
TTM Sales (₹ Cr.) 445 692
BVPS (₹) 220.2 298.1
Reserves (₹ Cr.) 279 383
P/BV 1.50 1.11
PE 0.00 13.37
From the Market
52 Week Low / High (₹) 321.00 / 332.85
All Time Low / High (₹) 47.00 / 669.90
Market Cap (₹ Cr.) 438
Equity (₹ Cr.) 13.3
Face Value (₹) 10
Industry PE 45.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Ciba India - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09
Sales439.82480.35477.60488.22454.44560.56624.04511.03468.19506.27
Operating Expenses + 406.77453.45446457.64430.05515.52572.91478.26437.62475.69
Manufacturing Costs11.6011.9414.6012.8012.7216.3818.1716.0112.8717.44
Material Costs362.88397.53384.56396.52372.12449.92498.23415.75380.29406.22
Employee Cost 12.3817.1417.7919.3120.3020.6624.1520.5918.0220.39
Other Costs 19.9226.8429.0529.0124.9128.5732.3725.9026.4431.64
Operating Profit 33.0526.9031.6030.5724.3945.0451.1332.7830.5730.59
Operating Profit Margin (%) 7.5%5.6%6.6%6.3%5.4%8.0%8.2%6.4%6.5%6.0%
Other Income + 7.6930.3731.7014.9214.318.6310.389.859.5011.08
Exceptional Items 000000060.1603.20
Interest 5.689.296.616.036.144.191.720.901.431.78
Depreciation 10.9413.5512.8112.0511.8410.059.077.896.849.55
Profit Before Tax 24.1134.4443.8827.4220.7239.4350.729431.8033.53
Tax 6.045.966.218.295.9412.3117.3512.9012.4611.17
Profit After Tax 18.0728.4837.6819.1314.7827.1233.3681.1019.3422.36
PAT Margin (%) 4.1%5.9%7.9%3.9%3.3%4.8%5.4%15.9%4.1%4.4%
Adjusted EPS (₹)13.621.428.414.411.120.425.161.114.616.8
Dividend Payout Ratio (%)33%28%32%31%36%27%28%8%24%21%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09

Equity and Liabilities

Shareholders Fund + 100.75120.10145.82158.21167185.79208.55281.28295.19312.10
Share Capital 13.2813.2813.2813.2813.2813.2813.2813.2813.2813.28
Reserves 87.47106.82132.54144.93153.71172.51195.27268281.90298.82
Debt +24.5261.0756.6581.0783.9321.533.047.6324.071.21
Long Term Debt24.5261.0756.6581.0783.9321.533.047.6324.071.21
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables41.1354.1146.1563.9951.5374.82111.1253.0376.4071
Others Liabilities 26.2431.1327.9924.2828.2732.0535.1427.3424.7728.25
Total Liabilities 192.64266.41276.60327.54330.73314.19357.85369.29420.43412.56

Fixed Assets

Net Fixed Assets +48.1344.5440.3038.8134.8030.9128.3926.8126.0745.54
Gross Block96.64104.73106.42116.22119.92124.45124.90114.42118.88134.80
Accumulated Depreciation48.5160.1966.1277.4085.1293.5496.5187.6192.8189.27
CWIP 1.851.591.170.661.111.936.8812.5713.170.22
Investments 16.7843.6963.6963.69100.4262.1263.92135.18150.86138.01
Inventories41.7173.4869.1991.3779.3577.23100.3868.2281.7085.14
Trade Receivables62.9284.0182.10111.5493.44118.79126.4173.0975.8271.69
Cash Equivalents 0.390.300.310.783.345.753.491.431.320.63
Others Assets 20.8518.8019.8420.6918.2717.4628.375271.4971.32
Total Assets 192.64266.41276.60327.54330.73314.19357.85369.29420.43412.56

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09
Cash Flow From Operating Activity + 24.145.2123.41-2.9148.7439.0935.64-8.8823.557.57
PBT 24.1115.1423.8224.2919.8239.4350.7233.8331.8030.33
Adjustment 16.6019.9518.1015.608.5810.405.492.011.855.45
Changes in Working Capital -6.05-23.65-9.26-40.2128.160.46-0.97-32.435.71-11.78
Tax Paid -10.52-6.23-9.25-2.59-7.83-11.20-19.59-12.29-15.81-16.42
Cash Flow From Investing Activity + -27.83-11.56-3.97-3.02-36.3936.08-9.3613.81-31.9321.84
Capex -26.21-8.1911.17-7.15-7.31-7.12-11.59-19.43-9.89-4.89
Net Investments -1.96-6.91-200-36.7438.30-1.80-70.98-15.608.77
Others 0.353.554.864.137.654.914.03104.21-6.4317.96
Cash Flow From Financing Activity + -0.915.76-19.436.39-9.79-72.76-28.54-6.998.26-30.10
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -5.01-8.71-6.23-6.07-5.90-4.37-1.72-0.97-0.49-1.78
Dividend Paid -3.98-5.98-7.97-11.95-5.98-5.31-7.30-9.30-6.64-4.65
Others 8.0720.45-5.2324.422.10-63.08-19.513.2815.39-23.67
Net Cash Flow -4.60-0.590.010.472.562.40-2.25-2.06-0.11-0.69

Finance Ratio

PARTICULARSMar'00Mar'01Mar'02Mar'03Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09
Ratios
ROE (%)19.0125.7928.3412.589.0915.3816.9233.116.717.36
ROCE (%)25.8428.5426.3215.1410.9619.0425.0437.9210.9311.16
Asset Turnover Ratio2.422.131.811.661.421.791.911.451.221.23
PAT to CFO Conversion(x)1.340.180.62-0.153.31.441.07-0.111.220.34
Working Capital Days
Receivable Days50556270806770695753
Inventory Days37435358674950585760
Payable Days48434649555068726266

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ciba India Ltd FAQs

The current trading price of Ciba India on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Ciba India stood at ₹438.3 Cr

The latest P/E ratio of Ciba India as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Ciba India as of 31-Dec-1969 is 1.50.

The 52-week high of Ciba India is ₹332.9 and the 52-week low is ₹321.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ciba India is ₹445 ( Cr.) .

About Ciba India Ltd

Ciba India, formerly known as Ciba Specialty Chemicals (India), is engaged in the manufacturing, selling and trading of a wide range of specialty chemicals. It was formed when the chemicals division of Hindustan Ciba-Geigy was hived off in 1996 and got its present name on December 19, 2007. The company is a part of Ciba, headquartered in Basel, Switzerland, with business interests in plastics, paper, automobiles, buildings, home and personal care products across more than 120 countries. The group's plant is located at Goa. The company offers specialty chemicals such as additives, coating chemicals, water treatment and paper treatment chemicals, home and fabric care chemicals and personal care chemicals to a number of industries including petrochemicals, lubricants, oil & gas, automobiles, paper, paints, plastics, inks, electronics material, packaging, water treatment, and home & personal care products.

The manufacturing facility located at Santa Monica in Goa is a global sourcing point for Ciba. Since March 2007, this facility manufactures UV absorbers. It continues to manufacture textile chemicals for Huntsman International (India) as a part of the agreement relating to sale of the erstwhile textile affects business. A research and technology center in Mumbai conducts specialized research and development activities. The business segments align closely with customer industries by offering integrated and complete solutions including a wide range of knowledge-based services and expertise and follow a tailored approach to individual customer needs creating strategic partnerships that link core competencies of the company with end-user markets. Virchow Drugs, a subsidiary, manufactures the antibacterial agent triclosan, which is used in personal care products like toothpaste, soaps and fabrics.

The registered office is located at Plot No. 37, Chandivali Farm Road, Chandivali, Andheri (East), Mumbai-400072.

Divisions:

  • Speciality chemicals segment - This segment includes coating chemicals, additives, water treatment and paper treatment chemicals, home and fabric care chemicals and personal care chemicals.
  • Other - The other segments include manufacture of under-contract and sourcing of products for exports.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×